The medication creates favorable conditions for weight loss, but your daily choices determine how much weight you actually lose
While research has shown that semaglutide helps to improve hemoglobin A1c levels (a marker for blood sugar control) and stabilize weight in people with type 2 diabetes, the drug has also been associated with certain gastrointestinal side effects
Tirzepatide, a dual GIP and GLP-1 receptor agonist marketed as Mounjaro and Zepbound, demonstrates substantial weight reduction in clinical trials, yet most patients experience periods where weight loss slows or temporarily stalls
Those who are taking the medication off label, meaning you dont fall into the category of diabetic or overweight enough to be on GLP-1s but have access to it anyway, may face even higher semaglutide costs
However, individuals with very low body fat may benefit from gently pinching the skin to create a fold of subcutaneous tissue, ensuring the needle reaches fatty tissue rather than muscle